These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17009449)

  • 1. Case studies in advanced monitoring: OptiVol.
    Tang WH
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S62-6. PubMed ID: 17009449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating monitoring into the infrastructure and workflow of routine practice: OptiVol.
    Small R
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S47-55. PubMed ID: 16955060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to monitoring heart failure before symptoms appear.
    Abraham WT
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S33-41. PubMed ID: 16955058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key lessons from cases worldwide.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):34G-40G. PubMed ID: 17512422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case studies in advanced monitoring with the Chronicle device.
    Bourge RC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S56-61. PubMed ID: 16955061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating device monitoring into the infrastructure and workflow of routine practice.
    Adamson PB
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S42-6. PubMed ID: 16955059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to monitoring and management of heart failure.
    Yancy CW
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S25-32. PubMed ID: 16955057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical link between heart failure self-care and intrathoracic impedance.
    Rathman LD; Lee CS; Sarkar S; Small RS
    J Cardiovasc Nurs; 2011; 26(4):E20-6. PubMed ID: 21076309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of automatic intrathoracic fluid content measurement into clinical decision making in patients with congestive heart failure.
    Knackstedt C; Mischke K; Schimpf T; Waringer J; Fache K; Frechen D; Gramley F; Kelm M; Schauerte P
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):961-7. PubMed ID: 18684251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of intrathoracic impedance monitoring in pediatric and congenital heart disease.
    LaPage MJ; von Alvensleben J; Dick M; Serwer G; Bradley DJ
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):994-9. PubMed ID: 23594286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study.
    Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G
    Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical approaches to the diagnosis of acute heart failure.
    Wong GC; Ayas NT
    Curr Opin Cardiol; 2007 May; 22(3):207-13. PubMed ID: 17413277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
    Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
    Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proactive monitoring: implications of implantable devices for future heart failure management.
    Daleiden-Burns A; Stiles P
    Crit Care Nurs Q; 2007; 30(4):321-8. PubMed ID: 17873568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.